Joseph P. O'Connell
2017 - Odonate Therapeutics
In 2017, Joseph P. O'Connell earned a total compensation of $2.8M as Chief Medical Officer at Odonate Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $60,000 |
|---|---|
| Option Awards | $2,590,030 |
| Salary | $108,712 |
| Other | $6,861 |
| Total | $2,765,603 |
O'Connell received $2.6M in option awards, accounting for 94% of the total pay in 2017.
O'Connell also received $60K in non-equity incentive plan, $108.7K in salary and $6.9K in other compensation.
Rankings
In 2017, Joseph P. O'Connell's compensation ranked 3,965th out of 14,666 executives tracked by ExecPay. In other words, O'Connell earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,965 out of 14,666 | 73rd |
Division Manufacturing | 1,389 out of 5,772 | 76th |
Major group Chemicals And Allied Products | 399 out of 2,075 | 81st |
Industry group Drugs | 308 out of 1,731 | 82nd |
Industry Pharmaceutical Preparations | 246 out of 1,333 | 82nd |
Source: SEC filing on June 1, 2018.
O'Connell's colleagues
We found two more compensation records of executives who worked with Joseph P. O'Connell at Odonate Therapeutics in 2017.
News
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2020 pay falls 31% to $1.4M
June 1, 2021
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2019 pay jumps 37% to $2M
May 15, 2020
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2018 pay jumps 465% to $1.4M
June 24, 2019